Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
1,105 people get NSPH articles and Market Currents by email alert.
Get email alerts on NSPH »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
Marketwire (May 15, 2013)
-
Marketwire (May 13, 2013)
-
Marketwire (Apr 25, 2013)
-
Marketwire (Mar 13, 2013)
-
-
-
Marketwire (Feb 22, 2013)
-
Marketwire (Feb 13, 2013)
-
-
Nanosphere to Release Q4 and Full Year 2012 Results and Hold Investor Call on Wednesday, February 13GlobeNewswire (Feb 5, 2013)
-
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Noteworthy Insider Buys And Sells In The Healthcare SectorGuruFundPicks • Fri, Jun 8, 2012
-
Nanosphere's CEO Discusses Q2 2012 Results - Earnings Call TranscriptTue, Aug 7, 2012 • 2 Comments
-
Nanosphere CEO Discusses Q3 2010 Results - Earnings Call TranscriptWed, Nov 3, 2010
-
Nanosphere, Inc. Q2 2010 Earnings Call TranscriptThu, Aug 5, 2010 • 2 Comments
-
Nanosphere, Inc. Q1 2010 Earnings Call TranscriptFri, May 7, 2010
-
Nanosphere, Inc. Q4 2008 Earnings Call TranscriptThu, Feb 26, 2009
-
Nanosphere, Inc. Q3 2008 Earnings Call TranscriptMon, Nov 10, 2008
-
Nanosphere, Inc. Q2 2008 Earnings Call TranscriptThu, Aug 14, 2008
-
Nanosphere Incorporation Q1 2008 Earnings Call TranscriptTue, May 13, 2008
-
Marketwire (May 15, 2013)
-
Marketwire (May 13, 2013)
-
Marketwire (Apr 25, 2013)
-
Marketwire (Mar 13, 2013)
-
Marketwire (Feb 22, 2013)
-
Marketwire (Feb 13, 2013)
-
Nanosphere to Release Q4 and Full Year 2012 Results and Hold Investor Call on Wednesday, February 13GlobeNewswire (Feb 5, 2013)
-
at MarketWatch.com (Jan 2, 2013)
-
GlobeNewswire (Dec 10, 2012)
-
GlobeNewswire (Nov 29, 2012)
-
GlobeNewswire (Nov 21, 2012)
-
GlobeNewswire (Nov 13, 2012)
-
GlobeNewswire (Nov 7, 2012)
-
GlobeNewswire (Nov 6, 2012)
-
GlobeNewswire (Nov 1, 2012)
-
GlobeNewswire (Oct 26, 2012)
NSPH vs. ETF Alternatives
Company Description
Currently, there's no company description for NSPH.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
-
Tuesday, May 14, 9:10 AM
Premarket gainers: PDII +33%. ECTY +20%. NSPH +18%. SNE +9%. WPX +8%. TTWO +6%. TSLA +6%. RENN +5%.
Losers: TRMD -15%. MOSY -13%. PT -11%. VELT -10%. SCTY -10%. TSL -6%. NBG -6%. 2 Comments [On the Move] - Monday, May 13, 8:53 PM Nanosphere (NSPH) expands into one of the world's largest health-care markets after signing a distribution and collaboration agreement with Hitachi High-Tech (HICTY.PK), giving the company exclusive rights to market NSPH's diagnostic test products in Japan. The two companies also plan to work together on assay and platform development. Terms of the agreement weren't disclosed. Shares +18% AH. Comment! [Healthcare, Global & FX, On the Move]
-
Monday, May 13, 5:45 PM
After-hours top gainers, as of 5:15 p.m.: PDII +26.9%. NSPH +20.1%. III +11.6%. TTWO +4.1%. NTI +2.9%.
After-hours top losers: MOSY -9.4%. ATAX -4.6%. SPH -4.3%. WES -3.9%. IMUC -3.6%. Comment! [On the Move] - Wednesday, March 13, 10:46 AM Nanosphere (NSPH +2.2%) said it's obtained the CE IVD Mark under the European Directive on In Vitro Diagnostic Medical Devices for its gram-negative blood-culture test on the automated sample-to-result Verigene System. The CE IVD Mark is a requirement for in vitro diagnostic medical devices marketed in Europe. Comment! [Healthcare, Global & FX, On the Move]
-
Friday, March 1, 1:01 PM
Midday top 10 gainers: GMXR +56%. RVLT +37%. MTG +24%. ANAC +15%. DECK +14%. NSPH +13%. KERX +13%. ATEC +13%. CRIS +12%. CIDM +12%.
Midday top 10 losers: SCMR -73%. AT -29%. RNIN -23%. LTBR -23%. FWLT -17%. MDR -14%. SUP -13%. SHIP -13%. MNOV -12%. CBMX -12%. Comment! [On the Move] - Friday, March 1, 10:55 AM Nanosphere (NSPH +9.7%) gets a boost from an initiation at Canaccord with a Buy rating and a $5 price target. Canaccord says NSPH is poised to capture a big chunk of the molecular diagnostics business after revamping its strategic approach last year ago to focus on blood stream infections. The company garnered FDA approval of its Gram-Positive Blood Culture Nucleic Acid Test in June 2012, and has become an early leader in the rapid detection of sepsis, which kills around 200K Americans annually and infects over 750K. Comment! [Healthcare, On the Move]
- Thursday, February 14, 3:58 PM Nanosphere (NSPH -30%) tanks today after it says that it sees FY13 sales of $13M to $15M, well under analyst expectations for $20.09M in sales this year. The company also said it is evaluating debt facilities to better manage working capital needs. Read more here: Earnings Call Transcript. 5 Comments [Healthcare, On the Move]
-
Thursday, February 14, 12:46 PM
Midday top 10 gainers: STZ +37%. ART +32%. ANGI +24%. EMITF +21%. HNZ +20%. FFEX +20%. MEIP +18%. VCLK +17%. SPWR +17%. DSCO +16%.
Midday top 10 losers: TBAC -40%. NSPH -31%. END -31%. CTL -22%. WTW -17%. STMP -16%. STRA -11%. ULTA -11%. TCX -11%. ITRI -10%. Comment! [On the Move] -
Thursday, February 14, 9:10 AM
Premarket gainers: ART +33%. ANGI +30%. STZ +29%. HNZ +20%. SKX +10%. ROSG +7%. Z +8%. ANR +7%. BUD +5%. EQIX +5%.
Losers: AFFY -22%. NSPH -20%. WTW -17%. CTL -17%. TRIP -10%. ULTA -9%. WFM -7%. BBRY -5%. ARR -6%. WIN -5%. 1 Comment [On the Move] -
Wednesday, February 13, 5:54 PM
After-hours top gainers, as of 5:15 p.m.: ANGI +21%. BCOR +12%. JCOM +7%. VCLK +6%. SGEN +5%.
After-hours top losers: STMP -24%. NSPH -22%. WTW -16%. CTL -16%. ITRI -10%. Comment! [On the Move] - Monday, December 10, 2012, 4:03 PM Nanosphere (NSPH +2.5%) says the FDA's granted 510(k) clearance permitting marketing of its C.difficile test on the automated Verigene System. The test, which can post results in less than two hours, expands Nanosphere's infectious disease test capabilities. C. difficile infection is a cause of diarrhea that can lead to colitis, other serious intestinal conditions and death, and rapid detection can prevent further spread of the infection. Comment! [Healthcare, On the Move]
- Tuesday, November 13, 2012, 12:32 PM Nanosphere (NSPH +3.5%) moves higher today after the FDA granted 510(k) clearance for the marketing of its CYP2C19 Nucleic Acid Test on the automated sample-to-result Verigene System. The test is used as an aid for clinicians to determine therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway by identifying variations directly from a patient's whole blood sample in less than 2.5 hours. Comment! [Healthcare, On the Move]
-
Tuesday, November 13, 2012, 9:10 AM
Premarket gainers: NSPH +15%. GALE +14%. HZNP +10%. NTI +10%. GBX +8%.
Losers: HCLP -15%. AKS -12%. NBG -11%. WFT -10%. SPIL -5%. Comment! [On the Move] - Tuesday, July 31, 2012, 3:42 PM Shares of Nanosphere (NSPH +4.5%) trade higher today after being upgraded by Piper Jaffray to Overweight this morning. The firm says that there has been meaningful activity since the company's Gram Positive test was approved. The firm also raises its price target to $4 from $2. Additionally, it's worth noting that there's been some significant insider buying in the shares recently. Comment! [Healthcare, On the Move]
- Thursday, July 19, 2012, 9:29 AM Nanosphere (NSPH) -3.5% premarket after the medical test developer announces its intention to offer 10.5M shares of common stock to raise proceeds for general corporate purposes and working capital. The $2.40/share price represents an 8% discount to yesterday's closing price. Comment! [Healthcare, On the Move]
- Monday, July 16, 2012, 9:24 AM Nanosphere (NSPH) -5% premarket after issuing downside guidance for Q2. NSPH sees Q2 revenues of $1.3M, +160% Y/Y but lower than the consensus estimate of $1.5M. Customer placements totaled 25, bringing cumulative placements to 166. Comment! [Healthcare, On the Move]
-
Ryan Mallory
Fuinhaz Setups for April 22 2013 | $BBRY $GOLD $HLIT $NSPH $PWER $SHPG $YHOO $ZNGA | SharePlanner http://bit.ly/13qxKHm - View all 28 replies
-
DumpsterDiver: Do you believe that note about PWER was NOT embarrassingly uninformed? If so, why? -
Ryan Mallory: No I don't, and what is more embarrassing is your obsession with a comment made 10 days ago.
-
ZetaKap
3 Low-Debt Healthcare Stocks Loaded With Cash http://bit.ly/QQjFw2 $BABY $HRC $NSPH @ZetaKap - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 8 replies
-
-
-
- View all 0 replies
-
Ryan Mallory
6 Big Volume Plays Setting Up Nicely http://bit.ly/MJX1Hw ELLI VRNG REXX SRPT NSPH WOOF - View all 0 replies
-
Scott Matusow
$NSPH beginning to break out in the rubber band wedge continuation triangle. I should get my short term target very soon of over $4 - View all 7 replies
-
-
alonfain: Scott - what's your opinion of the stock now, since it went above $3.5 and fell ?
-
- View all 1 replies
-
-
Scott Matusow
$NSPH - let's see what happens tomorrow, got a continuation triangle - bullish. $3.75 might be coming soon there - View all 3 replies
-
-
LATEST REPLIES
-
Ryan Mallory
Fuinhaz Setups for April 22 2013 | $BBRY $GOLD $HLIT $NSPH $PWER $SHPG $YHOO $ZNGA | SharePlanner http://bit.ly/13qxKHm - View all 28 replies
-
DumpsterDiver: Do you believe that note about PWER was NOT embarrassingly uninformed? If so, why?
-
Ryan Mallory: No I don't, and what is more embarrassing is your obsession with a comment made 10 days ago.
-
- View all 8 replies
-
-
-
Scott Matusow
$NSPH beginning to break out in the rubber band wedge continuation triangle. I should get my short term target very soon of over $4 - View all 7 replies
-
-
alonfain: Scott - what's your opinion of the stock now, since it went above $3.5 and fell ?
-
- View all 1 replies
-
-
Scott Matusow
$NSPH - let's see what happens tomorrow, got a continuation triangle - bullish. $3.75 might be coming soon there - View all 3 replies
-
-
-
- View all 3 replies
-
-